EP Wealth Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
EP Wealth Advisors's AZN Position: Q3 2026 in Review
EP Wealth Advisors reduced its AstraZeneca (AZN) stake by 36% in Q3 2026, selling an estimated $952K and leaving 10,345 shares worth $1.67M. The position accounts for 0.01% of the portfolio, ranked #549.
EP Wealth Advisors first reported a position in AZN in Q3 2019 and has held it in 25 quarters since. The position peaked at $3.04M in Q2 2026. 1,446 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- EP Wealth Advisors held 10,345 shares of AstraZeneca worth $1.67M as of Q3 2026.
- EP Wealth Advisors sold 5,710 AstraZeneca shares in Q3 2026, an estimated $952K.
- AstraZeneca made up 0.01% of EP Wealth Advisors's portfolio in Q3 2026, its #549 holding.
- EP Wealth Advisors first reported a position in AstraZeneca in Q3 2019 and has held it in 25 quarters since.
- EP Wealth Advisors's AstraZeneca position peaked at $3.04M in Q2 2026.
- 1,446 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on EP Wealth Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.